Harvard Bioscience published a recent study investigating how a brain-penetrating, bispecific amyloid-beta antibody distributes within the brain and interacts with aggregated Aβ in an Alzheimer’s disease mouse model using CMA Microdialysis technology.
Published
Signal category
Research & Knowledge
Quote
“In a recent 𝘕𝘦𝘶𝘳𝘰𝘵𝘩𝘦𝘳𝘢𝘱𝘦𝘶𝘵𝘪𝘤𝘴 study, researchers investigated how a brain-penetrating, bispecific amyloid-beta (Aβ) antibody distributes within the brain and interacts with different pools of aggregated Aβ in an Alzheimer’s disease mouse model.”
— Harvard Bioscience team
Company
Harvard Bioscience
Harvard Bioscience is a global leader in the manufacture and distribution of solutions to advance life science research.
- Industry
- Biotechnology Research
- Location
- Holliston, US
- Company size
- 408 employees
Harvard Bioscience is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. We sell our products to thousands of researchers in over 100 countries through our full-line catalog (and various other specialty catalogs), our websites, and through distributors, including GE Healthcare, Thermo Fisher Scientific Inc., and VWR. We have sales and manufacturing operations in the United States, the United Kingdom, Germany, and Spain and sales facilities in France and Canada.
Founded 1901